| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2000;102:1871.)
© 2000 American Heart Association, Inc.
Images in Cardiovascular Medicine |
From the Institute of Diagnostic Radiology (A.v.S., J.K.W., B.M.) and Heart Surgery (M.L.L., M.I.T.), University of Zurich, Zurich, Switzerland. Dr. DeBakey is a consultant.
Correspondence to Mario L. Lachat, MD, Department of Heart Surgery, Rämistrasse 100, 8091 Zurich, Switzerland.
A 52-year-old patient suffering from an extensive acute myocardial infarction of the left ventricle with a residual ejection fraction of 15% developed a rapidly progressive terminal heart insufficiency with low cardiac output syndrome and severe dyspnea. To bridge the time gap until transplantation, a new type of left ventricular assist device (DeBakey VAD) was implanted. The patient could be extubated 3 hours after surgery and returned to the regular ward on postoperative day 4 after an uncomplicated recovery.
The DeBakey VAD is a small (3.5-cm diameter and 76-mm
length), axial-flow blood pump with a titanium alloy for total
intracorporal implantation (Figure 1
),1 which has already been
successfully implanted in a few patients.2 Currently, our
experience includes 3 patients.
|
To assess the correct position of the system and the cannulas and to
exclude thrombotic material in the unloaded left
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |